¸ß·É
¸ß·É
ÁªÏµ·½Ê½£º³É¶¼ÊÐνÇøÁø̨´óµÀ1166ºÅmg老虎机游戏ҩѧ¥209
Email: feigao207@yeah.net
¸ß·É£¬²©Ê¿ºó£¬ÖÐҩѧ²©Ê¿£¬¸±Ñо¿Ô±£¬Ë¶Ê¿Ñо¿Éúµ¼Ê¦¡£2018Äê12Ô»ñÏã¸Û´óѧÀî¼Î³ÏҽѧԺ²©Ê¿Ñ§Î»£¬mg老虎机游戏±»ËÄ´¨Ê¡ÈËÁ¦ÓëÉç»á±£ÕÏÌüÆÀ¶¨Îª¸±Ñо¿Ô±£¬ËÄ´¨Ê¡º£Íâ¸ß²ã´ÎÈ˲ţ¬µÚÆßÅúËÄ´¨Ê¡ÖÐÒ½Ò©¹ÜÀí¾Ö¾ÖѧÊõÓë¼¼Êõ´øÍ·È˺ó±¸ÈËÑ¡£¬2021ÄêÈëÑ¡ËÄ´¨Ê¡¿Æ¼¼´´ÐÂÈ˲ţ¬2022ÄêÈëÑ¡ÖлªÖÐҽҩѧ»áÇàÄêÈ˲ÅÍоٹ¤³ÌAÀàÈ˲ţ»È«¹ú¸ßУ»Æ´óÄêʽ½ÌʦÍŶӡ°ÏµÍ³ÖÐÒ©´«³Ð´´Ð½ÌʦÍŶӡ±³ÉÔ±£¬¹ú¼ÒÖÐÒ½Ò©¶àѧ¿Æ½»²æ´´ÐÂÍŶӡ°Î÷ÄÏÌØÉ«ÖÐÒ©×ÊÔ´¶àάÆÀ¼Û¶àѧ¿Æ½»²æ´´ÐÂÍŶӡ±³ÉÔ±¡£
Ñо¿·½Ïò£º1. ͨ¹ý¡°Ê³Ò©½áºÏ¡±¡¢¡°¾úÒ©½áºÏ¡±ºÍ¡°Ò½Ò©½áºÏ¡±µÈ¶àѧ¿Æ½»²æ£¬´ÓÊÂÖÐÒ©ÐÂÐ͵ÝҩϵͳÑо¿£¬Ö÷Òª¾Û½¹´ó»Æ¡¢½ª»Æ¡¢½ðÒø»¨µÈÖÐÒ©ÓÐЧ³É·Ö¶Ô賦µÀ¡¢Ç°ÁÐÏÙºÍÖ×ÁöµÈÏà¹Ø¼²²¡£»2. ÖÐÒ©ÐÂÒ©¡¢±£½¡Æ·ºÍ»¯×±Æ·¿ª·¢ÓëÓ¦Óã»3. Ò½ÔºÖƼÁµÄ¿ª·¢ÓëÓ¦Óá£
×Ô2019Ä꣬µ£ÈζÀÁ¢PIÒÔÀ´£¬Ö÷³Ö¹ú¼Ò×ÔÈ»»ù½ðÃæÉÏÏîÄ¿£¬¹ú¼Ò×ÔÈ»»ù½ðÇàÄêÏîÄ¿¡¢Öйú²©Ê¿ºó»ù½ðÃæÉÏÏîÄ¿µÈ¹ú¼Ò¼¶¡¢Ê¡²¿¼¶µÈ¸÷¼¶ÏîÄ¿½ü10Ï½üÁ½Ä꣬ÒÔµÚÒ»/ͨѶ×÷ÕßÔÚAdvanced Drug Delivery Reviews£¬Carbohydrate Polymers£¬ACS Applied Materials & InterfacesµÈÔÓÖ¾·¢±íѧÊõÂÛÎĶþÊ®Óàƪ£¬ÆäÖÐIF£¾10ÂÛÎÄ5ƪ£¬ESI¸ß±»ÒýÂÛÎÄ1ƪ¡£
×÷Ϊ±àί³ö°æ¡¶ÖйúÁÙ´²Ò©Îï´ó´Çµä¡·¡¢¡¶ÖÐÒ©²ÄÊг¡³£¼ûÒ×»ìÆ·ÖÖ¼ø±ðͼ¼¯¡·µÈ½Ì²ÄרÖø5²¿£»ÈÙ»ñ2021Äê½ÌÓý²¿¸ßµÈѧУ¿ÆѧÑо¿ÓÅÐã³É¹û½±£¨¿Æѧ¼¼Êõ£©¶þµÈ½±£¬ÖÐÎ÷Ò½½áºÏѧ»á¿Æѧ¼¼Êõ½±ÈýµÈ½±µÈ£»»ñ¹ú¼Ò·¢Ã÷רÀû3ÏÉêÇë¹ú¼Ò·¢Ã÷רÀû3Ï²ÎÓë¶à¸ö²úÆ·µÄÉè¼ÆºÍ¿ª·¢£¬ÆäÖÐ×÷ΪÖ÷ÒªÖƼÁѧÑз¢¸ºÔðÈË£¬²úÆ·¡°ÁÆ¿µ¼Ñ¡±»ñÏã¸Û¿Æ¼¼Êð×ÊÖú£¬²úÆ·ÒÑÓÚÏã¸ÛÉÏÊС£
ÏÖΪËÄ´¨Ê¡ÆÕͨ¸ßУʡ¼¶Ò»Á÷¿Î³Ì»òÊ¡¼¶¿Î³Ì˼Õþʾ·¶¿Î³Ì¡¶ÖÐÒ©Ò©¼Áѧ¡·ºÍ¡¶ÖÐÒ©ÌáÈ¡¹¤ÒÕѧ¡·£¬ÒÔ¼°¡¶Ò©¼Áѧ¡·¡¢¡¶Ò©Óø¨ÁÏѧ¡·ºÍ¡¶ÖÐÒ©ÐÂÐ͸øҩϵͳÑо¿·½·¨Óë¼¼Êõ¡·Ö÷½²½Ìʦ£¬½Ìѧ³É¹ûÔÚÖйúÎ÷²¿ÖÐÒ½Ò©¸ßµÈ½Ìʦ·¢Õ¹ÁªÃË·ÖÏí£¬mg老虎机游戏»ñµÃmg老虎机游戏µÚÈý½ì¡°Î¢¿Î¡±´óÈüÒ»µÈ½±£¬2020Äê»ñ³É¶¼ÖÐÒ½Ò©´óÓÅÐã½Ìѧ°¸Àý£¬2021ÄêÈÙ»ñËÄ´¨Ê¡ÇàÄê½Ìʦ·ç²É´óÈü¶þµÈ½±£¬mg老虎机游戏½Ìѧ³É¹û½±ÌصȽ±ºÍÒ»µÈ½±¸÷1Ï2022Äê»ñËÄ´¨Ê¡½Ìѧ³É¹û½±¶þµÈ½±1Ïî¡£
¡î½ÌÓý¼°¹¤×÷¾Àú
2007/9¨C2011/6 mg老虎机游戏£¬Ò©Ñ§Ôº£¬ÖÐҩѧ£¨¹ú¼ÒÀí¿Æ»ù´¡¿ÆѧÑо¿ºÍ½ÌѧÈ˲ÅÅàÑø»ùµØ£©£¬±¾¿Æ
2011/9¨C2014/6 mg老虎机游戏£¬Ò©Ñ§Ôº£¬ÖÐÒ©Ò©¼Áѧ£¬Ë¶Ê¿£»µ¼Ê¦£º¸µ³¬ÃÀ
2014/9¨C2018/9 Ïã¸Û´óѧ£¬Àî¼Î³ÏҽѧԺ£¬ÖÐҩѧ£¬²©Ê¿£»µ¼Ê¦£º³Â½¨Æ¼
2018/12 ¨CÖÁ½ñ mg老虎机游戏£¬Ò©Ñ§Ôº£¬ÖÐÒ©ÅÚÖÆÓëÖƼÁϵ
¡î²¿·ÖÖ÷³ÖÏîÄ¿
1. ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðίԱ»á£¬ÃæÉÏÏîÄ¿£¬82274366£¬»ùÓÚ΢ÄÉÃ×¼¼ÊõÍÚ¾òPPsабêÑо¿´ó»Æ×é·Ö¡°ÇÐÔ´-Ö±»÷¡±ÐͬÖÎÁÆUC»úÖÆ£¬¸ºÔðÈË£¬2023
2. ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðίԱ»á£¬ÇàÄêÏîÄ¿£¬81903811£¬»ùÓÚ¡°ÃâÒß°ÐÏò-Öð¼¶ÊÍÒ©-¶à°ÐÏìÓ¦¡±µÄ´ó»Æ-èÙ×Ó×é·Ö¹²ÔØÄÉÃ×ÖÎÁÆÀ£ÑñÐԽ᳦Ñ×»úÖÆÑо¿£¬¸ºÔðÈË£¬2020
3. Öйú²©Ê¿ºó¿Æѧ»ù½ð»á£¬ÃæÉÏÏîÄ¿£¬2019M653364£¬¾©Äáƽ½»ÁªHSAÔØ´ó»ÆËá¿Ú·þÄÉÃ×ÖÎÁÆÀ£ÑñÐԽ᳦Ñ×Ñо¿£¬¸ºÔðÈË£¬2019
4. Öй²ËÄ´¨Ê¡Î¯×éÖ¯²¿/ËÄ´¨Ê¡¿Æѧ¼¼ÊõÌü/ËÄ´¨Ê¡ÈËÁ¦×ÊÔ´ÓëÉç»á±£ÕÏÌü£¬ËÄ´¨Ê¡Ì츮¡°ÍòÈ˼ƻ®¡±¿Æ¼¼Ý¼Ó¢£¬´¨ÍòÈ˵Ú653ºÅ£¬¸ºÔðÈË£¬2020
5. ËÄ´¨Ê¡¿Æѧ¼¼ÊõÌü£¬ËÄ´¨Ê¡¿Æ¼¼´´ÐÂÈ˲ţ¬2022JDRC0046£¬¸ºÔðÈË£¬2022
6. ÖлªÖÐҽҩѧ»á£¬ÖлªÖÐҽҩѧ»áÇàÄêÈ˲ÅÍоٹ¤³ÌAÀàÈ˲ţ¬2021-QNRC2-A09£¬¸ºÔðÈË£¬2022
7. ³É¶¼ÊпƼ¼¾Ö£¬ÖصãÑз¢Ö§³Å¼Æ»®£¬2019-YF05-00267-SN£¬»ùÓÚ¡°´ó»Æ-èÙ×Ó¡±Ò©¶Ô×é·ÖÅäÎéµÄ¶à¼¶ÊÍÒ©¿Ú·þ¹²ÔØ°×µ°°×ÄÉÃ×ÌåϵÖÎÁÆÀ£ÑñÐԽ᳦Ñ×Ñо¿£¬¸ºÔðÈË£¬2019
¡î²¿·Ö»ñ½±Çé¿ö
1. ÖлªÈËÃñ¹²ºÍ¹ú½ÌÓý²¿£¬ËÄÎïÖƼÁÖÊÁ¿ÌáÉý¹Ø¼ü¼¼Êõ¼°²úÒµ»¯Ó¦Ó㬽ÌÓý²¿¸ßµÈѧУ¿ÆѧÑо¿ÓÅÐã³É¹û½±£¨¿Æѧ¼¼Êõ£©¶þµÈ½±£¬2021
2. ÖйúÃñ×åҽҩлᣬ¼¦ÑªÌٵĴ´ÐÂÐÔÑо¿ÓëÓ¦Óã¬ÖйúÃñ×åҽҩлá¿Æѧ¼¼Êõ½±¶þµÈ½±£¬2021
3. ÖйúÖÐÎ÷Ò½½áºÏѧ»á£¬¼¦ÑªÌÙ¿¹ÈéÏÙ°©Ð²úÆ·¡¢Ð»úÖÆ¡¢ÐÂÓÃ;µÄϵͳÑо¿, ÖйúÖÐÎ÷Ò½½áºÏѧ»á¿Æѧ¼¼ÊõÈýµÈ½±, 2017
4. ËÄ´¨Ê¡½ÌÓýÌü£¬ÖÐҽҩԺУҩѧÀàרҵ¡°ÖÐÎ÷»ãͨ-²ú½ÌÈںϡ±ÐͬÓýÈËģʽµÄ´´ÐÂÓëʵ¼ù£¬ËÄ´¨Ê¡½Ìѧ³É¹û½±¶þµÈ½±£¬2022
5. ËÄ´¨Ê¡½ÌÓýÌü£¬ËÄ´¨Ê¡ÇàÄê½Ìʦ·ç²É´óÈü¶þµÈ½±£¬2021
¡î´ú±íÐԳɹû
2022Äê
1. Shanshan Qi#, Ruifeng Luo#, Xiaoqin Han, Wenbiao Nie, Naijing Ye*, Chaomei Fu*, Fei Gao*. pH/ROS Dual-Sensitive Natural Polysaccharide Nanoparticles Enhance ¡°One Stone Four Birds¡± Effect of Rhein on Ulcerative Colitis. ACS Applied Materials & Interfaces. 2022. IF: 10.383
2. Haiting Xu#, Wenbiao Nie#, Linxin Dai, Ruifeng Luo, Dasheng Lin, Minyue Zhang*, Jinming Zhang*, Fei Gao*. Recent Advances in Natural Polysaccharides-based Controlled Release Nanosystems for Anti-cancer Phototherapy. Carbohydrate Polymers. 2021. IF: 10.723
?3. Xiaoqin Han#, Ruifeng Luo#, Naijing Ye, Yichen Hu, Chaomei Fu, Ru Gao*, Shu Fu*, Fei Gao*. Research progress on natural ¦Â-glucan in intestinal diseases. International Journal of Biological Macromolecules. 2022. IF: 8.025
4. Haiting Xu, Ruifeng Luo, Lingling Donga, Xiulan Pu, Qiyan Chen, Naijing Ye, Shanshan Qi, Xiaoqin Han, Wenbiao Nie, Chaomei Fu, Jinming Zhang*, Fei Gao*. pH/ROS dual-sensitive poly (¦Â-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis. Nanomedicine: Nanotechnology, Biology and Medicine. 2022. IF: 6.458 ¸ß±»Òý
5. Lingling Dong, Hongling Du, Minyue Zhang, Haiting Xu, Xiulan Pu, Qiyan Chen, Ruifeng Luo, Yicheng Hu, Yitao Wang, He Tu, Jinming Zhang*, Fei Gao*. Anti-inflammatory effect of Rhein on ulcerative colitis via inhibiting PI3K/Akt/mTOR signaling pathway and regulating gut microbiota. Phytotherapy Research. 2022. IF: 6.388
6. Meisi Lin, Huiyun Zhong, Rita Lok Hay Yim, Qiyan Chen, Hongling Du, Haoqi He, Ke Lin, Peng Zhao, Ru Gao*, Fei Gao*, Minyue Zhang*. Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia. BMC Cancer. 2022. IF: 4.638
7. ¸ß·É*, ÖÓ»ÔÔÆ, ³Â¿Éìû, ¶ÁáÁá, ÁÖÃÀ˹, ¶ÅºèÁé*. ´ó»ÆÓÐЧ×é·Ö¡°´ó»ÆËá-´ó»Æ...ÁÆÀ£ÑñÐԽ᳦Ñ××÷ÓûúÖÆÑо¿. ÖйúÖÐÒ©ÔÓÖ¾. 2022:47(15), 4148-4155
8. ¸ß·É, ÖÜ·Æ, ¸Ê˧, ³ÂÑÅÀ¼, ¸µÊæ, ÁÖÃÀ˹, ¸µ³¬ÃÀ*. ËÄÄæÌÀÈ«·½Óë²ð·½Ö÷ҪҩЧ³É·Ö³¦ÎüÊÕ¶¯Á¦Ñ§¶Ô±ÈÑо¿. ÖйúÖÐÒ©ÔÓÖ¾. 2022:47(18), 5064-5070
9. ¸ß·É, ÂÞÈñ·æ, ÁÖÃÀ˹, Õ½òÃú, Õų¿, ʯ½ð·ï, ³ÂÆäÑÞ, ÁÎÍñ. Ò»ÖÖµ¥ÄþËὪ»ÆËØÄÉÃ×Á£×Ó¼°ÆäÖƱ¸·½·¨ºÍÓÃ;. Öйú·¢Ã÷רÀû. 2022. ÊÚȨרÀûºÅ: ZL 2020 1 1641258 .1
10. ¸ß·É, ÂÞÈñ·æ, ÁÖÃÀ˹, Õ½òÃú, ÁÎÍñ, ʯ½ð·ï, Õų¿, ³ÂÆäÑÞ. Ò»ÖÖÔØ´ó»ÆËáµÄÈéÌúµ°°×ÄÉÃ×Á£×Ó¼°ÆäÖƱ¸·½·¨ºÍÓÃ;. Öйú·¢Ã÷רÀû. 2022. ÊÚȨרÀûºÅ: ZL 2020 1 1510888 .5
2021Äê
1. Menghang Zu#, Ya Ma#, Brandon Cannup, Dengchao Xie, Yunjin Jung, Jinming Zhang, Chunhua Yang, Fei Gao*, Didier Merlin*, Bo Xiao*. Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases. Advanced Drug Delivery Reviews. 2021. IF: 17.873
2. Ruifeng Luo#, Meisi Lin#, Chaomei Fu, Jinming Zhang, Qiyan Chen, Chen Zhang, Jinfeng Shi, Xiulan Pu, Linlin Dong, Haiting Xu, Naijing Ye, Jiayi Sun, Dasheng Lin, Bin Deng, Arlene McDowell*, Shu Fu*, Fei Gao*. Calcium pectinate and hyaluronic acid modified lactoferrin nanoparticles loaded rhein with dual-targeting for ulcerative colitis treatment. Carbohydrate Polymers. 2021. IF: 10.723
3. Xiulan Pu#, Naijing Ye#, Meisi Lin#, Qiyan Chen, Lingling Dong, Haiting Xu, Ruifeng Luo, Xiaoqin Han, Shanshan Qi, Wenbiao Nie, Haoqi He, Yanli Wang, Linxin Dai, Dasheng Lin*, Fei Gao*. ¦Â-1,3-D-Glucan based yeast cell wall system loaded emodin with dual-targeting layers for ulcerative colitis treatment. Carbohydrate Polymers. 2021. IF=10.723
5. Ruifeng Luo#, Meisi Lin#, Chen Zhang, Jinfeng Shi, Siyuan Zhang, Qiyan Chen, Yichen Hu, Minyue Zhang, Jinming Zhang*, Fei Gao*. Genipin-crosslinked human serum albumin coating using a tannic acid layer for enhanced oral administration of curcumin in the treatment of ulcerative colitis. Food Chemistry. 2020. IF: 9.231
6. Qiyan Chen#, Ruifeng Luo#, Xiaoqin Han, Jinming Zhang, Yao He, Shanshan Qi, Xiulan Pu, Wenbiao Nie, Linlin Dong, Haiting Xu, Fang Liu, Meisi Lin, Huiyun Zhong, Chaomei Fu*, Fei Gao*. Entrapment of macrophage-target nanoparticles by yeast microparticles for rhein delivery in ulcerative colitis treatment. Biomacromolecules. 2021. IF: 6.978
7. Fei Gao#, Meisi Lin#, Jieshu You*, Minyue Zhang*, Long Cheng, Ke Lin, Peng Zhao, Qiyan Chen. Long-term outcomes of busulfan plus melphalan-based versus melphalan 200 mg/m2 conditioning regimens for autologous hematopoietic stem cell transplantation in patients with multiple myeloma: a systematic review and meta-analysi. Cancer Cell International. 2021. IF: 6.429
8. Minyue Zhang#, Fei Gao#, Ling Peng, Lijing Shen, Peng Zhao, Beiwen Ni, Jian Hou*, Honghui Huang*. Distinct clinical features and prognostic factors of hepatitis C virus-associated non-Hodgkin¡¯s lymphoma: a systematic review and meta-analysis. Cancer Cell International. 2021. IF: 6.429.
9. ³ÂÆäÑÞ, ¸µ³¬ÃÀ, ÂÞÈñ·æ, ÁÖÃÀ˹, ÁÎÍñ, ¸ß·É*. ´ó»Æ¼°ÆäÝìõ«¶Ô×ÔÉíÃâÒßÐÔ¼²²¡ÖÎÁƵÄÑо¿½øÕ¹. ÖйúÖÐÒ©ÔÓÖ¾. 2021:46(1), 15-23.
10. Ïʾ², Õų¿, ÖÓѩ÷, ¸µ³¬ÃÀ, ¸ß·É*, Õ½òÃú*. ÖÐÒ©»îÐԳɷֿڷþ½á³¦°ÐÏòÄÉÃ×ϵͳÖÎÁÆÀ£ÑñÐԽ᳦Ñ×µÄÑо¿½øÕ¹. ÖвÝÒ©. 2021:52(6), 1816-1826.
11. ÆÑÐãÀ¼, ÁÖÃÀ˹, ÂÞÈñ·æ, ³ÂÆäÑÞ, ¶ÁáÁá, ÁÖ´óʤ*, ¸ß·É*. PPsÔÚÃâÒßÏà¹Ø³¦²¡ÖеIJ¡Àí»úÖƼ°ÖÐÒ©¶àÌǵĵ÷¿Ø×÷ÓÃ. ÖйúʵÑé·½¼ÁѧÔÓÖ¾. 2021:27(4), 216-224.